Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Supplemntary material for artcle: Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-19
DOI
https://doi.org/10.5281/zenodo.14892214
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Zenodo (CERN European Organization for Nuclear Research)
Glioma Diagnosis and Treatment
article

Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

article en

Abstract

Supplemntary material for artcle: Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 34%
Glioma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Drug combinations targeting FAK and MEK overcomes tumour heterogeneity in glioblastoma · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS